BRCA1 and breast neoplasm: The aim of our study was to evaluate the effect of BRCA1-deleted (BRCA1+/−) iMSCs on breast tumor development and progression, compared to iMSCs that contained two copies of BRCA1 (BRCA1+/+ iMSCs).